Abstract
The generation of free radicals has been implicated in the pathologies of a number of cardiovascular diseases like infarction, stroke and atherosclerosis. Free radicals initiate lipid peroxidation, which leads to the impairment of membrane function and finally cell death. This often results in irrecoverable tissue damage. Therefore, potentially useful drugs would be those that not only have effects on the symptoms of the disease, but also demonstrate antioxidant and free radical scavenging properties. Some calcium entry blockers (CEBs) of the dihydropyridine (DHP) family (e.g. lacidipine, amlodipine, nifedipine) have been shown to possess radical scavenging activity in addition to their potent vasorelaxant properties. Some DHPs are active in inhibiting the autoperoxidation of rat cortical membranes. The order of potency was lacidipine>nimodipine>nifedipine, with lacidipine having an activity comparable to vitamin E. Lacidipine was also potent in protecting cells from the marked impairment of calcium homeostasis caused by oxidative stress induced by H2O2. Similarly, in the isolated rabbit heart electrolysis of the perfusion medium increases coronary artery pressure and this is antagonised by prior treatment with lacidipine. In vivo marked protection has been seen in animal models of vascular damage. In the stroke-prone spontaneously hypertensive rat lacidipine, at doses that do not block the development of hypertension, prevent mortality and tissue damage to brain and kidney, organs at risk in this model. Lacidipine also blocked the development of arterial lesions in two animal models of atherosclerosis : the hypercholesterolaemic rabbit and the hypercholesterolaemic hamster. These actions can be at least partially ascribed to mechanisms other than simple blood pressure reduction and might well relate to antioxidant activity.
Keywords
- Antioxidant Activity
- Calcium Antagonist
- High Density Lipoprotein
- Fatty Streak
- Reactive Oxygen Metabolite
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Halliwell, B... (1987) Oxidants and human disease: some new conceptts. FASEB J. 1: 358–364.
Cotgreave, I.A., Moldeus, P., and Orrenius, S. (1988) Host biochemical defense mechanisms against prooxidants. Ann. Rev. Pharmacol. Toxicol. 28: 189–212.
Kulmacz, R.J. and Lands, W.E.M. (1983) Requirement for hydroperoxide by the cyclooxigenase and peroxidase activities of prostaglandin H synthase. Prostaglandins, 25, 531–540.
Girotti, A.W. (1985) Mechanism of lipid peroxidation. J.Free Rad. Biol. Med. 1, 87–95.
Dean, R.T., Hunt, J.V., Grant, A.J., Yamamoto, Y., and Niki, E. (1991) Free radical damage to proteins: the influence of the relative localization of radical generation, antioxidants, and target proteins. Free Rad. Biol. Med. 11, 161–168.
Davies, K.J.A. (1987) Protein damage and degradation by oxygen radicals. I. General aspects. J.Biol.Chem. 262, 9895–9901.
Davies, K.J.A., Delsignore, M.E., and Sharon, W.L. (1987) Protein damage and degradation by oxygen radicals. II. Modification of amino acids. J.Biol.Chem. 262, 9902–9907.
Davies, K.J.A. and Delsignore, M.E. (1987) Protein damage and degradation by oxygen radicals. Ill. Modification of secondary and tertiary structure. J.Biol.Chem. 262, 9908–9913.
Fridrovich, I... (1984) Overview: bilolgical sources of 02-. Method Enzymol. 105, 59–61.
Simic, M.G., Jovanovic, S.V., and Niki, E. (1992) Mechanism of lipid oxidative process and their inhibition. ACS Symp.Ser. 500, 14–32.
Cross, A.R., Yea, C.M., and Jones, O.T.G. (1988) Inhibition of superoxide generation by phagocytic leukocytes. Biochem. Soc. Trans. 16, 888–889.
Rossi, F. (1986) The O2-forming NADPH oxidase of the phagocytes: nature, mechanism of activation and function. Biochim.Biophys.Acta, 853, 65–89.
Greenwald, R.A., Rush, S.W., Moak, S.A., and Weitz, Z. (1989) conversion of superoxide generated by polymorphonuclear leukocyt leokocites to hydroxyradical: a direct spectrophotometric detection system. Free Radical Biol. Med. 6, 385–392.
Deby, C. and Goutier, R. (1990) New perspectives on the biochemistry of superoxide anion and the efficency of superoxide dismutases. Biochem.Pharmacol. 39, 399–405.
Yamamoto, S. (1992) Mammalian lipoxygenases: molecular structures and functions. Biochim.Biophys.Acta, 1128, 117–131.
Condell, R.A. and Tappel, A.L. (1983) Evidence for suitability of glutatione peroxidase as protective enzyme: studies of oxidative damage, ranaturation and proteolysis. Arch.Biochem. 223,:407–416.
Maiorino, M., Gregolin, C., and Ursini, F. (1983) Phospholipid hydroperoxide glutatione peroxidase. Method Enzymol. 186, 448–457.
Ursini, F. and Bindoli, A. (1987) The role of selenium peroxidases in the protection against oxidative damage of membranes. Chem. Phys. Lipids, 44, 255–276.
Porter, N.A. (1984) Chemistry of lipid peroxidation. Method Enzymol. 105, 273–293.
Gardner, H.W. (1989) Oxygen radical chemistry of polyunsaturated fatty acids. Free Rad.Biol.Med. 7, 65–86.
Schaich, K.M. (1992) Metal and lipid oxidation. Contemporary issues. Lipids, 27, 209–218.
Thomas, C.E., Jackson, R., Ohlweiler, D.F., and Ku, G. (1994) Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells. J. Lipid Res. 35, 417–427.
Pryor, W.A. and Porter, N.A. (1990) Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Rad.Biol. Med. 8, 541–543.
Esterbauer, H., Schaur, R.J., and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxinonenal, malondialdehyde and related aldehydes. Free Rad.Biol. Med. 11, 81–128.
Brown, M.S. and Goldstein, J.L. (1983) Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Ann. Rev.Biochem. 52, 223–261.
Esterbauer, H., Gebicki, J., Puhl, H., and Jurgens, G. (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad.Biol. Med. 13, 341–390.
Ferrari, R., Ceconi, C., Curello, S., Cargnoni, A., Belloli, S., Condorelli, E., Pasini, E., Visioli, O., and Albertini, A. (1987) Molecular events during myocardial ischemia and reperfusion: experimental and clinical evidence. Biotechnology in Clinical Medicine, Raven Press Ltd, 25–44.
Esterbauer, H., Wag, G., and Puhl, H. (1993) Lipid peroxidation and its role in atherosclerosis. Brit.Med.Bull. 49, 566–576.
Schwartz, S.M. and Reidi, M.A. (1987) Common mechanisms of proliferation of smooth muscle in atherosclerosis and hypertension. Human pathology, 18, 140–247.
Kim, S., Ohta, K., Hamaguchi, A., Yukimura, T., Miura, K., and lwao, H. (1996) Effects of an AT1 receptor antagonist, on ACE inhibitor and a calcium channel antagonist on cardiac gene expression in hypertensive rats. Brit.J.Pharmacol. 118, 549–556.
Haynes, W.G. and Webb, D.J. (1993) The endothelin family of peptides: local hormones woth adverse in heart disease? Clin.Sci. 84, 485–500.
Utermann, G. (1989) The mistery of lipoprotein(a). Science, 246, 904–910.
Heinecke JW, R. (1987) The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J.Biol.Chem.: 262, 10098–10103
Heinecke JW, B. (1986), Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J.Clin.lnvest.: 77, 757–761
Partharasarathy S, Wieland, E., and Steinberg, D. (1988) Inhibition of endothelial cell-induced modification of low densi ty lipoprotein (LDL) by lipoxigenase inhibitors. Circulation, 78 supp 11: 14
Cathcart, M., McNally, A.K., and Chisolm, G.M. (1991) Lipoxygenase-mediated trasformation of human low density lipoprotein to an oxidized and cytotoxic complex. J.Lipid.Res. 32, 6370.
McNally, A.K., Chisolm III, G.M., Morel, D.W., and Catchart, M.K. (1990) Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway. J.Immunol. 145, 254–259.
Maiorino, M., Thomas, J.P., Girotti, A.W., and Ursini, F. (1991) Reactivity of phospholipid hydroperoxide glutathione peroxidase with membrane and lipoprotein lipids hydroperoxides. Free Rad. Res. Comms. 12–13, 131–135.
Thomas, J.P., Maiorino, M., Ursini, F., and Girotti, A.W. (1990): Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation. J.Biol.Chem. 265: 454–461.
Haenen, G.R.M.M., De Rooij, B.M., Vermeulen, N.P.E., and Bast, A. (1990) Mechanism of the reaction of ebselen with endogenous thiols: dihidrolipoate is a better cofactor than glutathione in the peroxidase. Mol.Pharmacol. 37, 412–422.
Thomas, C.E. and Jackson, C.E. (1991) Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoprotein. J.Pharmacol.Exp.Ther. 256, 1182–1188.
Kato, K., Shimamoto, N., and Hirata, M. (1988) Studies on scavengers of active oxygen species. 1. Synthesis and biological activity of 2–0-alkylascorbic acids. J.Med.Chem. 31, 793–798.
Burton, G.W. and Ingold, K.U. (1986) Vitamin E: application of the principle of physical organic chem chemistry to the exploration of its structure and function. Acc.Chem.Res. 19, 194–201.
Burton, G.W. and Ingold, K.U. (1981): Autoxidation of biological molecules: 1.The antioxidant activity of vitamin E and related chain-breaking antioxidants. J.Am.Chem.Soc. 103: 6472–6477.
Yoshioka, T., Fujita, T., Kanai, T., Aizawa, Y., Kurumada, T., Hasegawa, K., and Horikoshi, H. (1989) Horikoshi H Studies on hindered phenols and analogues. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation. J.Med.Chem. 32, 42 1428.
Buckley, M.M.T., Goa, K.L., Price, A.H., and Brogden, R.N. (1989) Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolemia. Drugs, 37, 761–800.
Hudson, B.J.F. and Lewis, J.I. (1983) Polyhydroxy flavonoid antioxidants for edible oils. Structural criteria fir activity. Food Chem. 10, 47–55.
Afanas’ev, I.B., Dorozhko, A.I., Brodskii, A.V., Kostyuk, V.A., and Potapovitch, A.I. (1989) Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem.Pharmacol. 38, 1763–1769.
Henry, P.D. (1990): Calcium channel blockers and atherosclerosis. J. Cardiovasc. Pharmacol. 16 (suppl.1): S 12-S 15.
Cosenza, C.A., Cramer, D.V., Cunneen, S.A., Tuso, P.J., Wang, H.K., and Malowka, L. (1994) Protective effect of the lazaroid U74006F in cold hischemia-reperfusion injury of the liver. Hepatology, 19, 418–425.
Hall, E.D., Braughler, J.M., Yonkers, P.A., Smith, S.L., Linseman, K.L., Means, E.D., Scherch, H.M., Von Voigtlander, P.F., Lahti, R.A., and Jacobsen, E.J. (1991) U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia. J.Pharmacol.Exp.Therap. 258, 688–694.
Carrea, F.P., Lesnefsky, E.J., Kaiser, D.G., and Horwitz, L.D. (1992) The lazaroid U74006F, a 21-aminosteroid inhibitor of lipid peroxidation, attenuates myocardial injury from ischemia and reperfusion. J.Cardiovasc.Pharmacol. 20, 230–235.
Hall, E.D. and McCall, J.M. (1993) Lazaroids: potent inhibitors of iron-dependent lipid peroxidation for neurodegenerativa disorders. Iron Cent.Nerv.Sys.Disord. Springer, Vienna, 173–188.
Nilsson, U.A., Olsson, L., Carlin, G., and Bylund-Fellenius, A. (1989) Inhibition of lipid peroxidation by spin labels Relationship between structure and function. J.Biol.Chem. 264, 11131–11135.
Kalyanaraman, B., Joseph, J., and Partharasarathy, S. (1993) The use of spin traps to investigate site-specific formation of free radicals in low-density lipoprotein oxidation. Biochem.Soc.Trans. 21, 318–321.
Lupo, E., Locher, R., Weisser, B., and Vetter, W. (1994) In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with a-tocopherol. Biochem.Biophys.Res.Commun. 203, 1803–1808.
Parmley, W.W., Blumlen, S., and Sievers, R. (1985) Modification of experimental atherosclerosis by calcium-channel blockers. Am.J.Cardiol. 55, 165B–171B.
Bernini, F., Catapano, A.L., Corsini, A., Fumagalli, R., and Paoletti, R. (1989) Effect of calcium antagonists on lipids and atherosclerosis. Am.J.Cardiol. 64, 1291–1341.
Weinstein, D.B. and Heider, J.G. (1989) Antiatherogenic properties of calcium antagonists. Am.J.Medicine, 86 (supp.4), 27–32.
Weinstein, D.B. and Heider, J.G. (1987) Antiatherogenic properties of calcium antagonists. Am.J.Cardiol. 59, 163B–172B.
Jackson, C.L., Bush, R.C., and Bowyer, D.E. (1989) Mechanism of antiatherogenic action of calcium antagonists. Atherosclerosis, 80, 17–26.
Kiowski, W., Eme, P., and Buhler, F.R. (1989) Effects of calcium antagonists on atherogenesis. Clin.Exp.Hypertens. Al 1(5 and 6 ), 10851096.
Weinstein, D.B. (1988) The antiatherogenic potential of calcium antagonists. J.Cardiovasc.Pharmacol. 12 (supp.6) S29 - S35.
Hugenholtz, P.G., Lichtlen, P., van der Giessen, W., Becker, A.E., Nayler, W.G., Fleckestein, A., and Hulsman, W.C. (1986) On a possible role for calcium antagonists in atherosclerosis. A personal view. Eur.Heart J. 7, 546–559.
Chobanian, A... (1987) Effects of calcium channel antagonists and other antihypertensiv drugs on atherogenesis. J.Hypertens. 5 (supp.4), S43 - S48.
Schmitz, G., Hankowitz, H., and Kovacs, E.M. (1991) Cellular processes in atherogenesis: potential targets of Ca++ channel blockers. Atherosclerosis, 88, 109–132.
Ouchi, Y. and Orimo, H. (1990) The role of calcium antagonists in the treatment of atherosclerosis and hypertension. J.Cardiovasc.Pharmacol. 16 Supp. 2, S1 - S4.
Kjieldsen, K. and Stender, S. (1989) Calcium antagonists and experimental atherosclerosis. Proc.Soc.Exp.Biol.Med. 190, 219–228.
Bernini, F., Corsini, A., Raiteri, M., Soma, M.R., and Paoletti, R. (1993) Effect of Lacidipine on experimental models of atherosclerosis. J.Hypertens. 11 supp 1, s61–;s66.
Nayler, W.G. and Panagiotopulos, S. (1993) The antiatherosclerotic effect of calcium antagonists and the implications in hypertension. Am. Heart J. 125, 626–629.
Betz, E., Weiss, H.D., Heinle, H., and Fotev, Z. (1991) Calcium antagonists and atherosclerosis. J. Cardiovasc.Pharmacol. 18 (supp1.10), S71 - S75.
Spedding, M. and Paoletti, R. (1992) Classification of calcium channels and the sites of action of drugs modifyng channel function. Pharmacol.Review, 44, 363–376.
Martens, F.M., Verhoeven, J.M., Varma, C.A.G.O., and Bergwerf, P. (1983) Photooxidation of 1,4-dihydropyridines by various electron acceptors: a laser flash photolysis study. J.Photochem. 22, 99–113.
Brewster, M.B., Pop, E., and Bodor, N. (1994) Contribution of the orbital techniques to the study of dihydropyridines. Heterocycles, 37, 1373–1415.
Janero, D.R., Burghart, B., and Lopez, R. (1988) Protection of cardiac membrane phospholipid against oxidative injury by calcium antagonists. Biochem.Pharmacol. 37, 4197–4203.
Janero, D.R. and Burghardt, B. (1989) Antiperoxidant effects of dihydropyridine calcium antagonists. Biochem.PharmacoI. 38, 43444348.
Mak, I.T. and Weglicki, W.B. (1990) Comparative antioxidant activities of propanolol,nifedipine, verapamil and diltiazem against sarcolemmal membrane lipid peroxidation. Circ.Res. 66, 1449–1452.
Mak, I.T., Boehme, P., and Weglicki, W.B. (1992): Antioxidant effect of calcium channel blockers against free radical injury in endothelial cells. Circ.Res. 70: 1099–1103.
Kim, Y.S., Yoon, Y.R., and Park, C.W. (1993) Protective effects of calcium antagonists and vitamin E on the ischemia-induced neuronal damage in brain slices. Korean J.Pharmacol. 29, 9–22.
Gaviraghi, G. (1989) Lacidipine, a new 1,4-dihydropyridine calcium channel antagonist possessing a potent and long lasting anthypertensive activity Trend Med. Chem. 88, 675–690.
van Amsterdam, F.T., Roveri, A., Majorino, M., Ratti, E., and Ursini, F. (1992) Lacidipine: a dihydropyridine calcium antagonist with antioxidant activity. Free Rad.Biol.Med. 12, 183–187.
Micheli, D., Ratti, E., Toson, G., and Gaviraghi, G. (1991) Pharmacology of lacidipine, a vascular-selective calcium antagonist. J. Cardiovasc. Pharmacol. 17 (Supp. 4), S1 - S8.
Ohkawa, H., Ohishi, N., and Yagi, K. (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal.Biochem. 95, 351–358.
Roveri, A., Coassin, M., Maiorino, M., Zamburlini, A., van Amsterdam, F.T., Ratti, E., and Ursini, F. (1992) Effect of hydrogen peroxide on calcium homeostasis in smooth muscle cells. Archiv.Biochem.Biophys. 297, 265–270.
Herbette, G., Gaviraghi, G., Tulenko, T., and Mason, R.P. (1992) Molecular interaction between lacidipine and biological membranes. J.Hypertens. 11 (suppl. 1), s13 - s19.
Herbette, L.G., Mason, P.E., Gaviraghi, G., Mason, R.P., and Trumbore, M. (1993) Thermodynamic basis for the molecular interactions of lacidipine with membranes. Biophys.J. 64 (2 part 2), A292
Cristofori, P., Sbarbati, A., Accordini, C., Terron, A., and Micheli, D. (1995) Protective action of lacidipine in cardiac hypertrophy of the spontaneously hypertensive stroke-prone rat: a ultrastructural study. J. Submicrosc. Cytol. Pathol. 26, 331–340.
Ursini, F. (1995) Mechanism of free radical oxidation and vascular damage: protective effect of dihydropyridines. Multiple risk factor in cardiovascular disease, Fondazione Giovanni Lorenzini,Milano
Feron, O., Solomone, S., and Godfraind, T. (1996) Action of the calcium channel blocker Lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats. Brit. J. Pharmacol. 118, 659–664.
Magagna, A., Taddei, S., Ghiadoni, L., Virdis, A., Uleri, S., and Salvetti, A. (1996) Effect of lacidipine on endothelial function in hypertensive patients. In Press
Bernini, F., Corsini, A., Raiteri, M., Soma, M.R., and Paoletti, R. (1992) Effect of Lacidipine on experimental models of atherosclerosis. J.Hypertens. 11 supp 1, s61–s66, 1993.
Soma, M.R., Parolini, C., Donetti, E., Galli, C., Paoletti, R., and Fumagalli, R. (1994) Lacidipine: in vivo effects on intimai carotid thickening in hypercholesterolemic rabbits. Br.J.Pharmacol. 111, 21 P
Cristofori, P., Micheli, D., Lanzoni, D., Spagnoli, D., Tarter, G., Pastorino, A., Sbarbati, A., Accordini, C., Osculati, F., Ratti, E., and Gaviraghi, G. (1993) Antiatherosclerotic activity of lacidipine in cholesterol-fed hamsters. Br.J.Pharmacol. 111, 270 P
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Gaviraghi, G., Pastorino, A.M., Ratti, E., Trist, D.G. (1997). Antioxidant Dihydropyridines, A New and Comprehensive Therapy for Free Radical-Induced Cardiovascular Diseases. In: Minisci, F. (eds) Free Radicals in Biology and Environment. NATO ASI Series, vol 27. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-1607-9_15
Download citation
DOI: https://doi.org/10.1007/978-94-017-1607-9_15
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-4831-8
Online ISBN: 978-94-017-1607-9
eBook Packages: Springer Book Archive